4 views left Get unlimited views with a free account

Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Progressive Supranuclear Palsy by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 44 ongoing clinical trials involving Progressive Supranuclear Palsy
Of the 44 trials,17 trials are in Phase III
Furthermore, 13 trials are in Phase I

Number of ongoing Clinical Trials (for drugs) involving Progressive Supranuclear Palsy by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Progressive Supranuclear Palsy, a central nervous system disorder. The largest number of ongoing clinical trials for Progressive Supranuclear Palsy is conducted in North America. Europe and Asia-Pacific are among some of the other prominent regions engaged in Progressive Supranuclear Palsy-related drug trials.

AlzProtect SAS: The leading ongoing Progressive Supranuclear Palsy related clinical trial sponsor

AlzProtect SAS is the top sponsor for Progressive Supranuclear Palsy-related ongoing clinical trials.

Cambridge University Hospitals NHS Foundation Trust, Inha University Hospital, California Pacific Medical Center Research Institute, and Novartis AG are among other notable clinical trial sponsors involved in Progressive Supranuclear Palsy. A clinical trial sponsor can be a Company, Government, Individual, or Institution.